TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.00E+3nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of CYP2E1 (unknown origin)More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.40E+4nMAssay Description:Inhibition of MAO-A (unknown origin) using tyramine as substrate after 30 to 60 mins by fluorescence plate reader analysisMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.90E+4nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of MAO-A (unknown origin) using tyramine as substrate after 30 to 60 mins by fluorescence plate reader analysisMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.50E+5nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >2.50E+5nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Micurx Pharmaceuticals
Curated by ChEMBL
Micurx Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: >2.70E+5nMAssay Description:Inhibition of human recombinant MAO-A expressed in yeast after 1 hr by luciferin-based luminescence assayMore data for this Ligand-Target Pair